A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma

NCT03534947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Carcinoma
Basal Cell Carcinoma of Skin, Site Unspecified
Skin Cancer
Invasive Carcinoma

Interventions

DRUG: Sonidegib
DRUG: Imiquimod
PROCEDURE: Surgery
OTHER: Best supportive care

Sponsor

Melanoma Institute Australia